Medtronic
Medtronic to Launch Deep Brain Simulation for Medically-Refractory Epilepsy in the U.S.
Epilepsy is a neurological disorder in which brain activity becomes abnormal, causing seizures or periods of unusual behavior, sensations, and sometimes loss of awareness....
Global Pulse Oximetry Market to Grow at a CAGR 6.2% During 2019-2025, According to...
The global pulse oximetry market will grow at a CAGR of 6.2% during the period of 2019-2025, according to Research and Markets analysis.Read more...
Medtronic’s Flex Embolization Device Receives FDA Approval for Brain Aneurysms
Medtronic received FDA approval for its Pipeline Flex embolization device to be used on patients with small or medium, wide-necked brain aneurysms in the...
Medtronic, IBM Watson Health Launch AI-Powered Hypoglycemia Prediction Feature on Sugar.IQ Diabetes App
Medtronic and IBM Watson Health launched a new feature for its Sugar.IQ personal diabetes assistant app that uses artificial intelligence (AI) technology from IBM...
Abbott, Medtronic Driving Deep Brain Stimulation Innovation for Parkinson’s Disease
Parkinson's disease is a progressive nervous system disorder that affects movement. Symptoms start gradually, sometimes starting with a barely noticeable tremor in just one...
Medtronic Buys AI-powered Nutrition Platform Nutrino to Boost Diabetes Offering
US Dublin-based med-tech company Medtronic announced that it will acquire Israeli nutrition-related data services, analytics, and technologies company and its long-time partner Nutrino Health...